JP2023519098A5 - - Google Patents

Info

Publication number
JP2023519098A5
JP2023519098A5 JP2022548585A JP2022548585A JP2023519098A5 JP 2023519098 A5 JP2023519098 A5 JP 2023519098A5 JP 2022548585 A JP2022548585 A JP 2022548585A JP 2022548585 A JP2022548585 A JP 2022548585A JP 2023519098 A5 JP2023519098 A5 JP 2023519098A5
Authority
JP
Japan
Prior art keywords
cells
composition
car
use according
ccr7
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022548585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023519098A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/017739 external-priority patent/WO2021163391A1/en
Publication of JP2023519098A publication Critical patent/JP2023519098A/ja
Publication of JP2023519098A5 publication Critical patent/JP2023519098A5/ja
Priority to JP2026057131A priority Critical patent/JP2026113543A/ja
Pending legal-status Critical Current

Links

JP2022548585A 2020-02-12 2021-02-11 Cd19指向性キメラ抗原受容体t細胞組成物ならびにその方法および使用 Pending JP2023519098A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026057131A JP2026113543A (ja) 2020-02-12 2026-03-31 Cd19指向性キメラ抗原受容体t細胞組成物ならびにその方法および使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062975724P 2020-02-12 2020-02-12
US62/975,724 2020-02-12
PCT/US2021/017739 WO2021163391A1 (en) 2020-02-12 2021-02-11 Cd19-directed chimeric antigen receptor t cell compositions and methods and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026057131A Division JP2026113543A (ja) 2020-02-12 2026-03-31 Cd19指向性キメラ抗原受容体t細胞組成物ならびにその方法および使用

Publications (2)

Publication Number Publication Date
JP2023519098A JP2023519098A (ja) 2023-05-10
JP2023519098A5 true JP2023519098A5 (cg-RX-API-DMAC10.html) 2024-02-21

Family

ID=74860463

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022548585A Pending JP2023519098A (ja) 2020-02-12 2021-02-11 Cd19指向性キメラ抗原受容体t細胞組成物ならびにその方法および使用
JP2026057131A Pending JP2026113543A (ja) 2020-02-12 2026-03-31 Cd19指向性キメラ抗原受容体t細胞組成物ならびにその方法および使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026057131A Pending JP2026113543A (ja) 2020-02-12 2026-03-31 Cd19指向性キメラ抗原受容体t細胞組成物ならびにその方法および使用

Country Status (11)

Country Link
US (1) US20230190798A1 (cg-RX-API-DMAC10.html)
EP (1) EP4103204A1 (cg-RX-API-DMAC10.html)
JP (2) JP2023519098A (cg-RX-API-DMAC10.html)
KR (1) KR20220152220A (cg-RX-API-DMAC10.html)
CN (1) CN115768443A (cg-RX-API-DMAC10.html)
AU (1) AU2021220875A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022015236A2 (cg-RX-API-DMAC10.html)
CA (1) CA3169672A1 (cg-RX-API-DMAC10.html)
IL (1) IL295384B2 (cg-RX-API-DMAC10.html)
MX (1) MX2022009832A (cg-RX-API-DMAC10.html)
WO (1) WO2021163391A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL292038B2 (en) 2014-04-23 2024-12-01 Juno Therapeutics Inc Methods for enriching or producing immune cell populations for adoptive therapy
BR112021002390A2 (pt) 2018-08-09 2021-05-11 Juno Therapeutics Inc processos para gerar células modificadas e suas composições
KR20210137085A (ko) 2019-03-05 2021-11-17 엔카르타, 인크. Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
WO2024097313A1 (en) * 2022-11-02 2024-05-10 Sana Biotechnology, Inc. Methods for producing t cell therapy products
EP4687963A1 (en) * 2023-03-30 2026-02-11 Cabaletta Bio, Inc. Methods and compositions for treating autoimmune diseases
US20240368273A1 (en) * 2023-05-03 2024-11-07 PELL Bio-Med Technology Co., Ltd. Murine anti-cd19 chimeric antigen receptor for treating cancer
KR20250074841A (ko) * 2023-11-20 2025-05-28 (재) 스크립스코리아항체연구원 키메라 항원 수용체를 발현하는 면역 세포 및 트렙타비딘 스캐폴드 항체 유사 단백질을 포함하는 항암용 조성물, 및 이의 용도

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361549A (en) 1979-04-26 1982-11-30 Ortho Pharmaceutical Corporation Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
US4452773A (en) 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
FR2540122B1 (fr) 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
JP2624470B2 (ja) 1984-10-02 1997-06-25 バイオジェン インコーポレイテッド ストレプトアビジン様ポリペプチドの製造
US4795698A (en) 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
US6352694B1 (en) 1994-06-03 2002-03-05 Genetics Institute, Inc. Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
ATE114507T1 (de) 1988-12-28 1994-12-15 Stefan Miltenyi Verfahren sowie materialien zur hochgraduierten magnetischen abspaltung biologischer materialien.
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
DE4228458A1 (de) 1992-08-27 1994-06-01 Beiersdorf Ag Multicistronische Expressionseinheiten und deren Verwendung
DE4237113B4 (de) 1992-11-03 2006-10-12 "Iba Gmbh" Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins
CA2164226C (en) 1993-06-04 2011-02-08 Carl H. June Methods for selectively stimulating proliferation of t cells
US5827642A (en) 1994-08-31 1998-10-27 Fred Hutchinson Cancer Research Center Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
WO1996024606A1 (en) 1995-02-09 1996-08-15 University Of Washington Modified-affinity streptavidin
WO1997011183A1 (en) 1995-04-11 1997-03-27 Trustees Of Boston University Streptavidin mutants
US5801115A (en) 1995-09-05 1998-09-01 Kataleuna Gmbh Catalyst composition and methods for using and preparing same
DE19608753C1 (de) 1996-03-06 1997-06-26 Medigene Gmbh Transduktionssystem und seine Verwendung
US6451995B1 (en) 1996-03-20 2002-09-17 Sloan-Kettering Institute For Cancer Research Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
ATE186235T1 (de) 1996-04-24 1999-11-15 Claude Fell Zelltrennungsvorrichtung für biologische flüssigkeiten wie blut
DE19641876B4 (de) 1996-10-10 2011-09-29 Iba Gmbh Streptavidinmuteine
CA2283716A1 (en) 1997-03-14 1998-09-17 Gabriel O. Reznik Multiflavor streptavidin
WO2000014257A1 (en) 1998-09-04 2000-03-16 Sloan-Kettering Institute For Cancer Research Fusion receptors specific for prostate-specific membrane antigen and uses thereof
AU2472400A (en) 1998-10-20 2000-05-08 City Of Hope CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
ES2224726T3 (es) 1998-12-24 2005-03-01 Biosafe S.A. Sistema de separacion sanguinea indicado en particular para la concentracion de celulas madre hematopoyeticas.
CA2410510A1 (en) 2000-06-02 2001-12-13 Memorial Sloan-Kettering Cancer Center Artificial antigen presenting cells and methods of use thereof
US7446179B2 (en) 2000-11-07 2008-11-04 City Of Hope CD19-specific chimeric T cell receptor
EP1227321A1 (en) 2000-12-28 2002-07-31 Institut für Bioanalytik GmbH Reversible MHC multimer staining for functional purification of antigen-specific T cells
DE10113776B4 (de) 2001-03-21 2012-08-09 "Iba Gmbh" Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins
US7070995B2 (en) 2001-04-11 2006-07-04 City Of Hope CE7-specific redirected immune cells
US20090257994A1 (en) 2001-04-30 2009-10-15 City Of Hope Chimeric immunoreceptor useful in treating human cancers
US7939059B2 (en) 2001-12-10 2011-05-10 California Institute Of Technology Method for the generation of antigen-specific lymphocytes
US7446190B2 (en) 2002-05-28 2008-11-04 Sloan-Kettering Institute For Cancer Research Nucleic acids encoding chimeric T cell receptors
US20050129671A1 (en) 2003-03-11 2005-06-16 City Of Hope Mammalian antigen-presenting T cells and bi-specific T cells
US20080171951A1 (en) 2005-03-23 2008-07-17 Claude Fell Integrated System for Collecting, Processing and Transplanting Cell Subsets, Including Adult Stem Cells, for Regenerative Medicine
US8389282B2 (en) 2007-03-30 2013-03-05 Memorial Sloan-Kettering Cancer Center Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
EP2520643B8 (en) 2007-12-07 2019-11-27 Miltenyi Biotec B.V. & Co. KG Sample processing systems and methods
US8479118B2 (en) 2007-12-10 2013-07-02 Microsoft Corporation Switching search providers within a browser search box
US20120164718A1 (en) 2008-05-06 2012-06-28 Innovative Micro Technology Removable/disposable apparatus for MEMS particle sorting device
JP5173594B2 (ja) 2008-05-27 2013-04-03 キヤノン株式会社 管理装置、画像形成装置及びそれらの処理方法
JP5956342B2 (ja) 2009-11-03 2016-07-27 シティ・オブ・ホープCity of Hope 形質導入T細胞選択のためのトランケート上皮増殖因子レセプタ(EGFRt)
PH12013501201A1 (en) 2010-12-09 2013-07-29 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
WO2012129514A1 (en) 2011-03-23 2012-09-27 Fred Hutchinson Cancer Research Center Method and compositions for cellular immunotherapy
US8398282B2 (en) 2011-05-12 2013-03-19 Delphi Technologies, Inc. Vehicle front lighting assembly and systems having a variable tint electrowetting element
ES2682750T5 (en) 2011-07-18 2025-02-04 Iba Lifesciences Gmbh Method of reversibly staining a target cell
WO2013071154A1 (en) 2011-11-11 2013-05-16 Fred Hutchinson Cancer Research Center Cyclin a1-targeted t-cell immunotherapy for cancer
EP2814846B1 (en) 2012-02-13 2020-01-08 Seattle Children's Hospital d/b/a Seattle Children's Research Institute Bispecific chimeric antigen receptors and therapeutic uses thereof
WO2013126726A1 (en) 2012-02-22 2013-08-29 The Trustees Of The University Of Pennsylvania Double transgenic t cells comprising a car and a tcr and their methods of use
SG11201404991YA (en) 2012-02-23 2014-09-26 Stage Cell Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
NZ702108A (en) 2012-05-03 2016-09-30 Hutchinson Fred Cancer Res Enhanced affinity t cell receptors and methods for making the same
LT2884999T (lt) 2012-08-20 2021-04-12 Fred Hutchinson Cancer Research Center Ląstelinės imunoterapijos būdas ir kompozicijos
RU2729401C2 (ru) 2012-10-02 2020-08-06 Мемориал Слоан-Кеттеринг Кэнсер Сентер Композиции и способы для иммунотерапии
US9599590B2 (en) 2012-10-12 2017-03-21 Sage Science, Inc. Side-eluting molecular fractionator
EP2920204B1 (en) 2012-11-16 2019-09-18 IBA GmbH Streptavidin muteins and methods of using them
JP5372297B1 (ja) 2012-12-20 2013-12-18 三菱電機株式会社 車載装置及びプログラム
CA2913052A1 (en) 2013-05-24 2014-11-27 Board Of Regents, The University Of Texas System Chimeric antigen receptor-targeting monoclonal antibodies
US9108442B2 (en) 2013-08-20 2015-08-18 Ricoh Company, Ltd. Image forming apparatus
NZ759969A (en) 2013-12-20 2022-12-23 Fred Hutchinson Cancer Center Tagged chimeric effector molecules and receptors thereof
RS62471B1 (sr) 2014-04-16 2021-11-30 Juno Therapeutics Gmbh Metode, kompleti i uređaji za proširenje populacije ćelija
IL292038B2 (en) 2014-04-23 2024-12-01 Juno Therapeutics Inc Methods for enriching or producing immune cell populations for adoptive therapy
TWI751102B (zh) 2014-08-28 2022-01-01 美商奇諾治療有限公司 對cd19具專一性之抗體及嵌合抗原受體
US10131901B2 (en) 2014-10-15 2018-11-20 Sage Science, Inc. Apparatuses, methods and systems for automated processing of nucleic acids and electrophoretic sample preparation
JP6740234B2 (ja) 2014-11-05 2020-08-12 ジュノー セラピューティクス インコーポレイテッド 形質導入および細胞プロセシングのための方法
RU2761555C2 (ru) 2015-10-22 2021-12-09 Джуно Терапьютикс Гмбх Способы, наборы, средства и устройства для трансдукции
JP6662164B2 (ja) 2016-04-14 2020-03-11 オムロンヘルスケア株式会社 圧脈波検出装置及び生体情報測定装置
WO2017214207A2 (en) * 2016-06-06 2017-12-14 Juno Therapeutics, Inc. Methods for the treatment of b cell malignancies using adoptive cell therapy
WO2018106732A1 (en) * 2016-12-05 2018-06-14 Juno Therapeutics, Inc. Production of engineered cells for adoptive cell therapy
AU2018260380B2 (en) 2017-04-27 2025-02-13 Juno Therapeutics Gmbh Oligomeric particle reagents and methods of use thereof
IL327498A (en) * 2017-06-02 2026-05-01 Juno Therapeutics Inc Articles of manufacture and methods for treatment using adoptive cell therapy
AU2019206724A1 (en) * 2018-01-15 2020-07-16 Kite Pharma, Inc. Methods of administering chimeric antigen receptor immunotherapy in combination with 4-1BB agonist

Similar Documents

Publication Publication Date Title
JP7673272B2 (ja) キメラ受容体及びその使用方法
JP2022512917A5 (cg-RX-API-DMAC10.html)
TWI842703B (zh) Dll3 的嵌合受體及其使用方法
JP2023519099A5 (cg-RX-API-DMAC10.html)
TWI707950B (zh) 結合分子和使用彼之方法
CN112638947B (zh) 用于治疗实体瘤的嵌合抗原受体细胞
EP3875484A1 (en) Cll1-targeting antibody and application thereof
AU2025203410A1 (en) Anti-TCR antibody molecules and uses thereof
JP2020510657A (ja) 抗cd16a抗体のサイトカインとの組み合わせ
IL261941B1 (en) Chimeric antigen and t cell receptors and methods of use
JP7429882B2 (ja) キメラ抗原受容体を発現する粘膜関連インバリアントt(mait)細胞
IL295384A (en) Preparations of t cells with a chimeric antigen receptor directed against cd19 and methods and uses thereof
AU2019314452B2 (en) Chimeric antigen receptor therapy T cell expansion kinetics and uses thereof
TW200307129A (en) Compositions and methods for restoring immune responsiveness in patients with immunological defects
JP2024542159A5 (cg-RX-API-DMAC10.html)
KR20210033025A (ko) Steap1에 대한 키메라 수용체 및 이의 사용 방법
US20060228351A1 (en) Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor
CA3060426C (en) Humanized antigen-binding domains against cd19 and methods of use
JP2026502532A (ja) T細胞及びnk細胞悪性腫瘍の免疫療法のためのcd8発現及びキメラ抗原受容体の遮断
JP2025540909A (ja) 免疫療法のためのcd3発現及びキメラ抗原受容体の遮断
HK40057006B (en) Chimeric receptors, methods therefor and uses thereof
EA040586B1 (ru) Химерные рецепторы и способы их применения
OA19499A (en) Chimeric antigen and T cell receptors and methods of use.
CA3060426A1 (en) Humanized antigen-binding domains against cd19 and methods of use